Retroperitoneal sarcomas (RPS) are rare cancers representing only 0.2% of cancers in adults with an average annual incidence of approximately 2.7 cases per million. The mainstay of treatment for RPS is surgical resection, and complete resection is the only chance for potential cure. The management of RPS can be challenging and in individual cases, radiation and systemic therapy may be beneficial in both primary and recurrent disease.
Webinar (FAD sincrona)
Accreditamento ECM per medici – infermieri
Gentile Utente, l’accesso a questo contenuto è riservato.